New report shows high-impact R & D happens after cancer medicines are first approved

A new report showcasing nine critical oncology treatments, highlights the vital role of post-approval research and development (R&D) in advancing cancer treatment options and deliveringunprecedented progress in the fight against cancer over the past 10 years.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development PhRMA Member Company Cancer Government Price Setting Source Type: news